Structure Therapeutics Inc. American Depositary Shares (GPCR) Stock Analysis

Structure Therapeutics Inc. American Depositary Shares (GPCR) is a publicly traded company in the HEALTHCARE sector. It trades at $37.19, carries a market capitalization of $2.74B. This page summarizes the public market data, fundamentals, and frequently asked questions for GPCR, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Structure Therapeutics Inc. American Depositary Shares currently has a Neutral sentiment score of 0.02.

About Structure Therapeutics Inc. American Depositary Shares

Structure Therapeutics Inc. (GPCR) is a clinical-stage biopharmaceutical company based in South San Francisco, California, dedicated to developing innovative oral therapeutics for chronic diseases with substantial unmet medical needs. The company boasts a promising pipeline of drug candidates, leveraging advanced scientific methodologies and a robust patient-centric focus to create effective treatment solutions. With its commitment to improving patient outcomes, Structure Therapeutics is well...

GNG Research Analysis

GNG Research scores Structure Therapeutics Inc. American Depositary Shares (GPCR) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for GPCR.

Frequently Asked Questions

Does GPCR pay dividends?

Structure Therapeutics Inc. American Depositary Shares (GPCR) does not currently pay a regular dividend.

What is GPCR's market cap?

Structure Therapeutics Inc. American Depositary Shares (GPCR) has a market capitalization of $2.74B with a current stock price of $37.19.